Market Closed

LSTA
Lisata Therapeutics
$ 1.21
-5.47%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago

Lisata Therapeutics News

Latest Lisata Therapeutics Stock News & LSTA Headlines

Marea Therapeutics, a Subsidiary of Lisata Therapeutics, to Participate in Upcoming November Investor Conferences
11 days ago | globenewswire.com
Lisata adds biopharma finance veteran Jeffrey Farrow to board
a month ago | proactiveinvestors.com
Financial Survey: Lisata Therapeutics (NASDAQ:LSTA) vs. Dyadic International (NASDAQ:DYAI)
a month ago | defenseworld.net
Lisata Therapeutics Appoints Jeff Farrow to Board of Directors
a month ago | globenewswire.com
Lisata Therapeutics wins new US patent for pancreatic cancer drug
a month ago | proactiveinvestors.com
Lisata Therapeutics Announces New Method of Use Patent Granted for Certepetide in the Treatment of Pancreatic Cancer and Other Solid Tumors
a month ago | globenewswire.com
Lisata subsidiary Marea Therapeutics gets late-breaking slot at AHA Scientific Sessions
2 months ago | proactiveinvestors.com
Nano Cap Lisata Therapeutics Bolsters Cardioendocrine Pipeline Strategy
2 months ago | benzinga.com
Lisata Therapeutics acquires Marea Therapeutics, secures $225 million private placement
2 months ago | proactiveinvestors.com
Lisata Therapeutics Announces Acquisition of Marea Therapeutics and $225 Million Concurrent Private Placement
2 months ago | globenewswire.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

LSTA
Lisata Therapeutics
$ 1.21
-5.47%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago